✦ LIBER ✦

A Phase I/II Clinical Trial in Localized Prostate Cancer of an Adenovirus Expressing Nitroreductase with CB1984

✍ Scribed by Patel, Prashant; Young, J Graham; Mautner, Vivien; Ashdown, Daniel; Bonney, Sarah; Pineda, Robert G; Collins, Stuart I; Searle, Peter F; Hull, Diana; Peers, Elizabeth; Chester, John; Wallace, D Michael; Doherty, Alan; Leung, Hing; Young, Lawrence S; James, Nicholas D

Book ID: 121448531
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 316 KB
Volume: 17
Category: Article
ISSN: 1525-0016
DOI: 10.1038/mt.2009.80

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical trials with direct intr

Phase I clinical trials with direct intratumoural injection of an adenovirus-nitroreductase (Ad-NTR) vector, CTL102, in liver and prostate tumour patients

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Clinical Protocol: Phase I Study of an A

Clinical Protocol: Phase I Study of an Adenovirus/Prostate-Specific Antigen Vaccine in Men with Metastatic Prostate Cancer

✍ Lubaroff, David M.; Konety, Badrinath; Link, Brian K.; Ratliff, Timothy L.; Mads 📂 Article 📅 2006 🏛 Mary Ann Liebert 🌐 English ⚖ 95 KB

Evaluation of phase I/II clinical trials

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides

✍ Tjoa, B.A.; Simmons, S.J.; Bowes, V.A.; Ragde, H.; Rogers, M.; Elgamal, A.; Kenn 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB 👁 2 views

## Background: A phase i trial involving patients with advanced prostate cancer was conducted to assess the safe administration of dendritic cells (dc) and hla-a0201-specific prostate-specific membrane antigen (psma) peptides (psm-p1 or -p2). thirty-three of the phase i participants were subsequent

A phase I trial of DNA vaccination with

A phase I trial of DNA vaccination with a plasmid expressing prostate-specific antigen in patients with hormone-refractory prostate cancer

✍ Pavlenko, M; Roos, A-K; Lundqvist, A; Palmborg, A; Miller, A M; Ozenci, V; Bergm 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 135 KB

Phase 2 study of neoadjuvant docetaxel p

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer : A Prostate Cancer Clinical Trials Consortium trial

✍ Robert W. Ross; Matthew D. Galsky; Phil Febbo; Marc Barry; Jerome P. Richie; Wan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

Phase I/II clinical trial of anti-OX40,

Phase I/II clinical trial of anti-OX40, radiation and cyclophosphamide in patients with prostate cancer: immunological analysis

✍ Magdalena Kovacsovics-Bankowski,Lana Chisholm… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 65 KB